Cargando…
COMPARATIVE EFFICACY OF CENTBUTINDOLE & RISPERIDONE IN SCHIZOPHRENIA
Centbutindole is a new antipsychotic agent related to butyrophenone group. The drug is dopamine antagonist but it also blocks 5HT(2) receptors. Clinically the drug has passed through phase I, II & III clinical trials successfully and it has shown effective antipsychotic activity in schizophrenic...
Autores principales: | Chandra, R., Singh, H., Dalal, P.K., Asthana, O.P., Srivastava, J.S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955309/ https://www.ncbi.nlm.nih.gov/pubmed/21206602 |
Ejemplares similares
-
A COMPARATIVE EFFICACY STUDY OF CENTBUTINDOLE AND HALOPERIDOL IN SCHIZOPHRENIA
por: Singh, Harjeet, et al.
Publicado: (1999) -
Randomized controlled trial of standardized Bacopa monniera extract in age-associated memory impairment
por: Raghav, Sangeeta, et al.
Publicado: (2006) -
SERUM LIPID PROFILE IN SUICIDE ATTEMPTERS
por: Verma, Sandeep, et al.
Publicado: (1999) -
RISPERIDONE IN INDIAN PATIENTS WITH SCHIZOPHRENIA
por: Agarwal, A.K., et al.
Publicado: (1998) -
SERUM LIPIDS : NEW BIOLOGICAL MARKERS IN DEPRESSION ?
por: Khalid, Abdul, et al.
Publicado: (1998)